GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Zenotech Laboratories Ltd

Zenotech Laboratories Q2 FY27 Net Loss Rs. 257.33 Lakhs

RESULTS ▼ Concern Flagged HIGH RISK
📅 Filed on BSE: 28 Oct 2026, 02:21 PM IST  ·  BSE ID: 3bf51b2d-519e-4711-9660-002a2404f6d3
View Original BSE Filing (PDF)
💡
In Simple Terms
The company reported a Net Loss of Rs. 257.33 Lakhs for the September 2026 quarter, alongside Rs. 613.15 Lakhs in revenue.
🤖 AI Summary
  • Zenotech Laboratories reported a Net Loss of Rs. 257.33 Lakhs for the quarter ended September 30, 2026.
  • Revenue from operations was Rs. 613.15 Lakhs for the September 30, 2026 quarter.
  • For the half-year, Net Loss was Rs. 302.88 Lakhs, with Revenue from operations at Rs. 1,572.79 Lakhs.
  • Total assets as of September 30, 2026, amounted to Rs. 10,987.56 Lakhs.
  • The Board of Directors approved the unaudited standalone financial results for Q2 and H1 FY27.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Revenue from operations (Q2 FY27)
Rs. 613.15 Lakhs
-40.09%
Net Profit/(Loss) for the period (Q2 FY27)
Rs. (257.33) Lakhs
Not comparable — prior period data is negative.
Revenue from operations (H1 FY27)
Rs. 1,572.79 Lakhs
-16.65%
Net Profit/(Loss) for the period (H1 FY27)
Rs. (302.88) Lakhs
Not comparable — prior period data is negative.
Total Assets (as at Sep 30, 2026)
Rs. 10,987.56 Lakhs
Basic Earnings/(loss) per share (H1 FY27)
Rs. (0.50)
Not comparable — prior period data is positive.
🏢 How This Affects the Company
📈
Business Impact
The company's revenue from operations for Q2 FY27 was Rs. 613.15 Lakhs, representing a decrease from Rs. 1,023.19 Lakhs in the comparable prior year quarter. Half-year revenue from operations also declined to Rs. 1,572.79 Lakhs from Rs. 1,887.10 Lakhs in the prior half-year.
💰
Financial Impact
Zenotech Laboratories recorded a Net Loss of Rs. 257.33 Lakhs for Q2 FY27 and a Net Loss of Rs. 302.88 Lakhs for H1 FY27. This compares to a Net Profit of Rs. 15.30 Lakhs in H1 FY26. Total assets decreased to Rs. 10,987.56 Lakhs from Rs. 11,115.35 Lakhs as of March 31, 2026.
⚠️
Risk Impact
Sustained net losses and declining revenue from operations increase financial performance risks for the company. Basic Earnings per share for H1 FY27 is a loss of Rs. (0.50), down from a profit of Rs. 0.03 in H1 FY26.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders based on this financial results filing.
👤
Who Is Affected
All shareholders are affected by the company's financial performance, specifically the reported Net Loss of Rs. 257.33 Lakhs for Q2 FY27 and Rs. 302.88 Lakhs for H1 FY27, impacting other equity.
🔍
Management Signal
The financial results indicate that management is focused on navigating operational challenges amidst declining revenue and persistent losses, as evidenced by the Q2 FY27 performance.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Q3 FY27 financial results — check for revenue trends and loss reduction efforts.
Any updates on operational strategies to improve profitability.
Balance sheet changes — monitor cash and cash equivalents.
HIGH RISK The company reported sustained net losses and declining revenue, indicating significant financial challenges.
💡 Investor Takeaway
Zenotech Laboratories reported a Net Loss of Rs. 257.33 Lakhs for the quarter ended September 30, 2026. Revenue from operations was Rs. 613.15 Lakhs. For the half-year, the Net Loss stood at Rs. 302.88 Lakhs. This marks a continuation of net losses from the previous quarter and a decline in half-year revenue compared to the prior year.
⚖️ Strengths & Concerns

⚠️ Concerns

  • Zenotech Laboratories reported a Net Loss of Rs. 257.33 Lakhs for the quarter ended September 30, 2026.
  • Revenue from operations for the September 2026 quarter decreased to Rs. 613.15 Lakhs from Rs. 1,023.19 Lakhs in the prior year comparable quarter.
📅 Company Track Record
Zenotech Laboratories reported a Net Loss of Rs. 45.55 Lakhs in Q1 FY27, preceded by an FY26 net loss of Rs. 107.21 Lakhs. This contrasts with a prior year profit of Rs. 561.29 Lakhs in FY25, which was impacted by a Rs. 477.18 Lakhs deferred tax charge in FY26. The company has shown a trend of increasing losses since FY25.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
What was Zenotech Laboratories' Net Loss for Q2 FY27?
Zenotech Laboratories reported a Net Loss of Rs. 257.33 Lakhs for the quarter ended September 30, 2026.
What was Zenotech Laboratories' Revenue from operations in Q2 FY27?
Revenue from operations for Zenotech Laboratories was Rs. 613.15 Lakhs for the quarter ended September 30, 2026.
What was Zenotech Laboratories' Net Loss for the half-year ended September 30, 2026?
For the half-year ended September 30, 2026, Zenotech Laboratories reported a Net Loss of Rs. 302.88 Lakhs.
What were Zenotech Laboratories' total assets as of September 30, 2026?
Total assets for Zenotech Laboratories stood at Rs. 10,987.56 Lakhs as of September 30, 2026.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.